- Physician-in-Chief, University Hospitals
- Chair, Department of Medicine, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Robert Salata, MD, is the STERIS Chair of Excellence in Medicine and Chairman of the Department of Medicine since 2015 and was Chief of the Division of Infectious Diseases and HIV Medicine for nearly 20 years at Case Western Reserve University and University Hospitals Cleveland Medical Center. He is the founding Director of the Infectious Diseases and Immunology Institute in the School of Medicine and also Medical Director of Infection Control and Prevention at UH Cleveland Medical Center. He has been an active principal investigator on HIV/AIDS-related research studies for the Uganda-Case Western Reserve University Research Collaboration since 1997. His clinical interests in the evaluation and management of infections in immunocompromised hosts and healthcare–associated infections. His research interests in the epidemiology of infectious diseases, clinical trials of new therapeutic agents for emerging infections and clinical HIV/AIDS research related to antiretrovirals including in resource-limited settings, as well as the epidemiology and prevention of HIV.
Dr. Salata has been considered a consummate clinician and educator and have been so recognized with a Department of Medicine Teacher of the Year award, as a Master Clinician Educator in the Department of Medicine and the inaugural recipient of the Master Clinician in Infectious Diseases at UH Cleveland Medical Center. He was recently recognized a Distinguished physician at University Hospitals. He is internationally recognized as a researcher in clinical trials and has received continuous funding for these activities from the National Institutes of Health. Taking advantage of over 30 years of a collaboration in Uganda, he has also facilitated the involvement of multiple other areas of chronic non-communicable diseases in global health, including cardiovascular medicine, oncology, neurology and genetics
Dr. Salata has authored 243 peer-reviewed publications, 150 reviews/chapters, and 210 abstracts. He is the Chair of the AAIM Research Committee and was Vice-Chair of the APM Research Committee prior to that, and for two years served as Chair of the 3rd Consensus Conference on the physician scientist and was 1st author of a 2017 Academic Medicine publication entitled “U.S. Physician-Scientist Workforce in the 21st Century: Recommendations to Attract and Sustain the Pipeline.” Three additional publications have emanated from the work done on the Research Committee in the American Journal of Medicine and JCI Insight (see CV). He continues to foster various research initiatives through AAIM Research Committee, including Physician Scientist Residency Research, Education Research, the Innovation Grants program and new initiatives in Population Health Research as well as Research integrity.
- Infectious Diseases
- Nosocomial Infections
- Orthopaedic Infections
- Transplant Infections
- Travel Medicine
Certifications & Memberships
- Infectious Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - University Hospitals Of Cleveland (1985 - 1986)
Fellowship | Infectious Disease
Infectious Disease - University Of Virginia Medical Center (1982 - 1985)
Residency | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1980 - 1982)
Internship | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1979 - 1980)
Case Western Reserve University (1979)
University Of Notre Dame (1974)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Robert Salata disclosed the following Outside Relationships with Industry:
- - STERIS Corporation - Consulting